Evidence map›Paper›PMID 32535809›Full record

ArticleHuman genetics2020

Complex chromosomal rearrangements of human chromosome 21 in a patient manifesting clinical features partially overlapped with that of Down syndrome.

Taichi Imaizumi, Keiko Yamamoto-Shimojima, Tomoe Yanagishita, Yumiko Ondo, Eriko Nishi, Nobuhiko Okamoto, Toshiyuki Yamamoto

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Taichi ImaizumiInstitute of Medical Genetics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ward, Tokyo, 162-8666, Japan.
Keiko Yamamoto-ShimojimaInstitute of Medical Genetics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ward, Tokyo, 162-8666, Japan.
Tomoe YanagishitaInstitute of Medical Genetics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ward, Tokyo, 162-8666, Japan.
Yumiko OndoInstitute of Medical Genetics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ward, Tokyo, 162-8666, Japan.
Eriko NishiDepartment of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.
Nobuhiko OkamotoDepartment of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.
Toshiyuki YamamotoInstitute of Medical Genetics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ward, Tokyo, 162-8666, Japan. yamamoto.toshiyuki@twmu.ac.jp.ORCID http://orcid.org/0000-0002-9484-3505
Osaka Women's and Children's Hospital · JPSt. Marianna University School of Medicine · JPTokyo Women's Medical University · JPJapan Society for the Promotion of Science · JP

Funding

Japan Society for the Promotion of Science JP18K07803Japan Society for the Promotion of Science (JP) 17K18133
6 · The paper itself

Abstract

The chromosomal region critical in Down syndrome has long been analyzed through genotype-phenotype correlation studies using data from many patients with partial trisomy 21. Owing to that, a relatively small region of human chromosome 21 (35.9 ~ 38.0 Mb) has been considered as Down syndrome critical region (DSCR). In this study, microarray-based comparative genomic hybridization analysis identified complex rearrangements of chromosome 21 in a patient manifesting clinical features partially overlapped with that of Down syndrome. Although the patient did not show up-slanting palpebral fissures and single transverse palmar creases, other symptoms were consistent with Down syndrome. Rearrangements were analyzed by whole-genome sequencing using Nanopore long-read sequencing. The analysis revealed that chromosome 21 was fragmented into seven segments and reassembled by six connected points. Among 12 breakpoints, 5 are located within the short region and overlapped with repeated segments. The rearrangement resulted in a maximum gain of five copies, but no region showed loss of genomic copy numbers. Breakpoint-junctions showed no homologous region. Based on these findings, chromoanasynthesis was considered as the mechanism. Although the distal 21q22.13 region was not included in the aberrant regions, some of the genes located on the duplicated regions, SOD1, SON, ITSN1, RCAN1, and RUNX1, were considered as possible candidate genes for clinical features of the patient. We discussed the critical region for Down syndrome, with the literature review.

Indexed as

Adaptor Proteins, Vesicular TransportChromosome AberrationsChromosomes, HumanChromosomes, Human, Pair 21Comparative Genomic HybridizationCore Binding Factor Alpha 2 SubunitDNA-Binding ProteinsDown SyndromeFemaleGene DosageGenetic Association StudiesHumansInfantIn Situ Hybridization, FluorescenceMicroarray AnalysisMinor Histocompatibility AntigensAdaptor Proteins, Vesicular TransportCore Binding Factor Alpha 2 SubunitDNA-Binding ProteinsITSN1 protein, humanMinor Histocompatibility AntigensMuscle ProteinsRCAN1 protein, humanRUNX1 protein, humanSOD1 protein, humanSON protein, humanSuperoxide Dismutase-1

Identifiers

PMID32535809
OpenAlexW3035662816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.